To investigate whether miniature pigs are useful for evaluating the potential of drugs for drug-induced prolongation of the QT interval, we performed an in vivo QT assay using conscious and unrestricted miniature pigs. Compared with the vehicle average baseline values, haloperidol at 3 and 10 mg / kg, p.o. prolonged the QTcF interval (Fridericia's formula) by 8% -16%. The plasma concentration of haloperidol at which QT interval was prolonged (C max = 42.9 ng / mL) was almost equal to that in humans. dl-Propranolol at 3, 10, and 30 mg / kg, p.o. caused no alterations in QT interval. dl-Propranolol at 3, 10, and 30 mg / kg, at which plasma concentrations were lower than in humans treated with dl-propranolol at the therapeutic dose level, shortened QTcF interval by 7% -12%. dl-Sotalol at 10 mg / kg, p.o. prolonged QTcF interval by 7%. From the above results, we considered that the miniature pig can be used for prediction of drug-induced prolongation of QT interval in humans, and thus, it is one of the useful animal species for assessing electrocardiograms in safety pharmacology studies.
Introduction
Pigs and miniature pigs have often been used for a long time as experimental animals both for in vivo and in vitro studies on the cardiovascular system, including studies to assess efficacy of drugs for cardiovascular diseases because these animals have many physiological similarities to humans (1 -4) . To assess the safety of pharmaceuticals in non-clinical studies, it is preferable to use the same animal species in investigations such as efficacy assessment studies to surmise the safety margin and other important properties of drugs. However, pigs and miniature pigs have been used for toxicity studies less frequently with few studies about this animal species being published to date. The scarcity of background data on this species is one of the reasons these animals have not been used more frequently. At present, in safety pharmacology studies, effects of drugs on the cardiovascular systems are assessed mainly with dogs or monkeys, so that there were almost no validation data necessary for assessment of effects on the cardiovascular system with pigs or miniature pigs. Furthermore, researchers are apt to shrink from the use of pigs especially for long-term studies since they grow up quickly to large body size. Miniature pigs, which weigh approximately 50 kg even at maturity and are relatively manageable, have many anatomical and physiological similarities to humans, including a similar organ size and cardiovascular systems (4) . Therefore, miniature pigs have an ample possibility for use in safety pharmacology studies.
To investigate whether miniature pigs are useful for assessing the effects of drugs on cardiovascular parameters in safety pharmacology studies, we examined the effects of 3 compounds on blood pressure, heart rate, and electrocardiograms with a telemetry system in unrestricted conscious miniature pigs. The compounds used were the dopamine D 2 antagonist haloperidol and the adrenergic β receptor antagonist dl-sotalol, both positive compounds that are known to cause QT interval prolongation and associated arrhythmias in humans (5, 6) , and the adrenergic β receptor antagonist dl-pro-pranolol, a negative compound that is believed not to have such effects (7) . Relationships between changes in QT interval caused by haloperidol and dl-propranolol and plasma concentrations were also examined.
Materials and Methods
The present study was performed according to the modified standard protocol established by a joint project "QT Interval Prolongation: Project for Database Construction (QT PRODACT)", which was organized by member companies of the Japanese Pharmaceutical Manufacturing Association (JPMA) and Japan Association of Contract Laboratories for Safety Evaluation (JACL). In addition, integrating the non-clinical, clinical, and other relevant information are needed to assess the safety of each compound in humans. It is, therefore, impossible to evaluate the safety of each compound in humans based only on the results obtained in this study.
Compounds
Haloperidol (Wako Pure Chemical Industries, Ltd., Osaka), dl-propranolol hydrochloride (called "dl-propranolol" hereafter; Sigma Chemical Company, St. Louis, MO, USA), and dl-sotalol hydrochloride (80 mg /dl-sotalol tablet; called "dl-sotalol" hereafter; Bristol Pharmaceuticals K.K., Tokyo) were used. A 0.5% solution of methylcellulose [called "0.5% MC" hereafter; methylcellulose (400 cP, Wako Pure Chemical Industries) dissolved in water for injection (Otsuka Pharmaceutical Factory, Inc., Tokushima)] served as the vehicle for the compounds. The 0.5% MC was used within 8 days of preparation, and dosing preparations were made up by suspending each compound in the 0.5% MC when they were needed.
Animals
This study was performed in accordance with criteria of the regulations defined by the committee of experimental animals of Nihon Bioresearch, Inc. and the Guiding Principles for the Care and Use of Laboratory Animals approved by The Japanese Pharmacological Society. For the present study, 4 male miniature pigs (NIBS; Nisseiken Co., Ltd., Tokyo) aged 6 -9 months, weighing 17.0 -17.5 kg, were used. The animals were housed individually in stainless steel cages (W: 1190 × D: 590 × H: 720 mm) placed in an animal room on a 12-h light and dark cycle (lighting: 06:00 -18:00) with a temperature range of 22°C -24°C and a relative humidity range of 43% -84%. The animals were given 350 g of solid feed (MP; Oriental Yeast Co., Ltd., Tokyo) per day. Considering the time to the maximum plasma concentration (T max ) of haloperidol in humans (8) , the animals were fed after completion of blood collection accompanying the measurement of electrocardiographic parameters performed 8 h after administration. When the animals were treated with dl-propranolol or dl-sotalol, the animals were fed at the same time as the feeding time of haloperidol to avoid occurrence of different diurnal rhythms among the animals used for examining effects of the 3 compounds. The animals were fed at around 18:30 the day before administration to synchronize the feeding time on the day of administration. The animals were fasted for 14 h or longer the day before administration and were given free access to tap water through the nozzles of automatic water dispensers.
Telemetry system
The telemetry system used consisted of a transmitter (TL11M2-D70-PCP; Data Sciences International, Arden Hills, MN, USA), a receiver (RLA200 or RMC-1, Data Sciences International), and a data exchange matrix system (UA-10, Data Sciences International) and automated data analysis software (SBP-97 ver. 5.01; Softron Co., Ltd., Tokyo). Using these tools and equipment, blood pressure, heart rate, and electrocardiographic parameters were measured.
Surgery for implantation of transmitters and catheters for blood sample collection
Surgery for implantation of the transmitters and catheters for blood sample collection was properly performed according to the fundamental veterinary methods as follows: After intramuscular injection of atropine sulfate (Tanabe Seiyaku Co., Ltd., Osaka) at 0.05 mg / kg, the animals were first anesthetized intramuscularly with ketamine hydrochloride (Sankyo Co., Ltd., Tokyo) at 15 mg / kg, and then the anesthesia was maintained by inhalation of 0.5% -1.5% isoflurane (Dainabot Co., Ltd., Tokyo) with a gas mixture of N 2 O and O 2 at a ratio of 1:1.
A transmitter was implanted subcutaneously into the left ventral part of the animal. A sensor for measuring blood pressure was inserted from the femoral artery so as to extend its tip to the abdominal aorta. To obtain electrocardiograms of M-X (9), an electrode (−) was implanted subcutaneously at a right outer site covering the second and third intercostal regions, and another electrode (+) was implanted subcutaneously at a site above the Manubrium sterni. A cannula (UK-II CV catheter; Nippon Sherwood Medical Industries, Ltd., Tokyo) was inserted into the vena cava, and the other end of the cannula was fixed to the cervical skin with sutures and reinforced with elastic fabric adhesive tape (Elastpore; Nichiban, Tokyo). For 3 days after surgery (the day of surgery included), the animals were given intramuscular injection of ampicillin sodium (VICCILLIN FOR INJECTION; Meiji Seika Kaisha, Ltd., Tokyo) at 500 mg / body per day, and isodine gel (Meiji Seika Kaisha) was locally applied to the wound caused by surgery. To prevent blood coagulation within the cannula, heparin lock was performed at least once every 3 days after surgery. After allowing the animals to recover from surgery for 2 weeks or longer, animals in which the surgery wound had completely healed were used for the experiments.
Experimental protocol
Electrocardiograms were recorded with the telemetry system continuously from 25 h before the administration to 24 h after administration to confirm diurnal rhythm and to find a more preferable formula to obtain corrected QT interval. The compounds were orally administered to the animals with a gastolic tube between 10:00 and 10:30. Haloperidol at 0 (vehicle alone), 1, 3, and 10 mg / kg and dl-sotalol at 0 (vehicle alone) and 10 mg / kg were administered to the animals by a doseescalation method, while dl-propranolol at 0 (vehicle alone), 3, 10, and 30 mg / kg was administered by the Latin Square method. Each animal was treated with the 3 drugs at different dose levels at intervals of 3 days or longer. Since there was little information concerning drug-induced QT interval prolongation in miniature pigs, the dose levels of haloperidol and dl-sotalol were determined with reference to the dose levels at which they prolonged QT interval in dogs (5, 10, 11) . The dose levels of dl-propranolol were determined with reference to the blood concentrations at its efficacious dose level in humans or dogs (12 -15) . The recordings were performed under quiet conditions; except for cleanup of the animal room and cages, dosing, feeding, and blood collection, human entry to the animal room was restricted. Animal cages were cleaned so as not to affect the measurement as far as possible.
Cardiovascular parameters analyzed
To examine the diurnal changes in RR and QT intervals in the animals, the baseline QT-RR relationship was investigated for all animals by analyzing 9 consecutive electrocardiographic waves every 6 min over a 24-h period before the start of a series of experiments. Following Bazett's and Fridericia's formulas (see below), which are the most commonly used in dogs, QTc interval was calculated from the QT and RR intervals.
Bazett's formula: QTcB = QT / RR 1/ 2 (16) Fridericia's formula: QTcF = QT/ RR 1/ 3 (17) To find a formula more preferable for correcting the QT interval in miniature pigs, individual correction coefficients (β) were corrected for the heart rate of each animal by the method of Spence et al. (18) according to the formulas shown below; the slopes of linear regression obtained by the logarithmic scale of QT and RR intervals for each animal are defined as the correction coefficient β. Then, using the obtained correction coefficients, QT intervals were corrected for each animal following the individual correction (QTci) shown below.
The correction coefficients obtained by individual correction were compared with correction coefficients in the above 2 formulas (0.5 in Bazett's formula and 0.33 in Fridericia's formula).
Then, QTc-RR plots were distributed using QTcB, QTcF, and QTci. Slopes of linear regression in the distribution of QTc-RR plots were obtained for all animals or for each animal, and the slopes of linear regression obtained by individual correction were compared with those obtained by the 2 other formulas.
The mean blood pressure, heart rate, PR interval, RR interval, QRS duration, QT interval, and QTcF interval obtained before administration (the means of readings obtained at 3 measurement points of time) and 1, 2, 4, 8, and 24 h after administration (also 0.5 h after administration for dl-sotalol) were analyzed and evaluated. Nine consecutive waves were selected from the electrocardiograms obtained over a 3-min period of time around each measured time point, and the above cardiovascular parameters were analyzed with the automated data analyis software.
For determination of plasma concentrations of haloperidol and dl-propranolol, blood (3 mL) was collected via a cannula from the animals treated with haloperidol and those treated with dl-propranolol before administration and 1, 2, 4, 8, and 24 h after administration. Blood collection was performed within 5 min of completing the measurement of electrocardiographic parameters at each measurement time. The collected blood was put into heparinized blood collection tubes (VP-H050; Terumo Corporation, Tokyo), and plasma was separated by centrifugation at 4°C and 1912 × g for 15 min. The plasma samples were stored frozen at -80°C until determination of plasma concentrations of haloperidol and dl-propranolol by an enzyme-immunoassay method (20) and HPLC (21), respectively.
Statistical analyses
Data on diurnal changes in QT and RR intervals for 24 h were shown as means with standard errors (S.E.M.) for 4 animals at each measured time point. Data on the cardiovascular parameters, which were obtained after treatment with each compound and the vehicle, were shown as mean percentage differences from the 24-h vehicle average baseline value with standard deviations (S.D.) at each dose level of each compound. As the 24-h vehicle average baseline values, we used the average values of the cardiovascular parameters for each animal obtained at all measured time points before and after administration of the vehicle (3 points before administration and 5 or 6 points after administration). The slopes, which were obtained by the 3 formulas and shown as means with S.D., were compared by paired t-tests among individual correction, Bazett's formula, and Fridericia's formula. Cardiovascular parameter data obtained in the haloperidol study was analyzed by repeated measurement ANOVA with dose-escalation design and those in the dl-propranolol experiment were analyzed by repeated measurement ANOVA with Latin square design. A Dunnett type multiple comparison test was conducted to compare parameters between each dose group and the vehicle group using model variance. When significant differences were seen at certain dose levels or significant differences were seen in the dose × time interaction, effects of the compound at certain dose levels or effects of the compound at all time points were tested by the ttest. Repeated measurement with dose-escalation design was conducted for cardiovascular parameter data obtained in animals administered dl-sotalol. When significant differences were seen in compound effects or significant differences were seen in the dose × time interaction, effects of the compound at all time points were tested by the t-test. Correlation between QTcF interval and plasma concentration was statistically tested by Spearman's rank method. Values of P<0.05 were regarded as statistically significant. SAS software (Version 8.02; SAS Institute, Cary, CN, USA) and SAS Application for Preclinical Study (Version 5.0, SAS Institute) were used for the data analyses. Figure 1 shows diurnal changes in RR and QT intervals for 24 h in the animals. Except for during the cleanup time and feeding time, no marked differences were seen in RR or QT interval between the light and dark periods. Both parameters were shortened during the cleanup time and feeding time. These changes in RR interval were noted in parallel with those in QT interval except that the RR interval reverted to level of the daytime RR interval over 2 or 3 h after feeding, whereas the QT interval reverted to that before feeding immediately after completion of feeding. Figure 2 (A, B, and C) shows distributions of QTc-RR plots for 24 h in the test animals. The slope of linear regression obtained by Fridericia's formula (slope = −0.0623) (B) was gentler than that by Bazett's formula (slope = −0.1653) (A). The slope of linear regression obtained by individual correction (slope = −0.0475) (C) was similar to that by Fridericia's formula. QTc interval obtained by any formula tended to be more prolonged if the RR interval was short and tended to be shortened if the RR interval was long. When the RR interval was approximately 450 ms or shorter (heart rate was 135 beats / min or higher), the QTc-RR plots were far from the slopes of linear regression obtained by any of the 3 formulas. Table 1 shows slopes of linear regression in the distribution of QTc-RR plots, where the correction coefficient β, obtained by correcting QT interval for each animal, was used. The averaged correction coefficient in 4 animals was 0.2862 ± 0.0435 (0.2382 -0.3426), which was more similar to the correction coefficient by Fridericia's formula (0.33) than that by Bazett's formula (0.5). The slopes of linear regression obtained by Fridericia's formula and by individual correction were significantly gentler than those by Bazett's formula, but no significant difference was seen between the slopes of linear regression by Fridericia's formula and those by individual correction. Table 2 shows cardiovascular changes caused by haloperidol, and Table 4 shows changes in plasma concentration at the times when haloperidol was administered. Compared with the vehicle control values, haloperidol at 1, 3, and 10 mg / kg caused no alterations in mean blood pressure or heart rate. Compared with the vehicle control values, haloperidol at 1, 3, and 10 mg / kg caused no alterations in PR interval or QRS duration, but at 10 mg / kg, it significantly prolonged QT interval by 10% -15% (62.0 -78.5 ng / mL) at 2 -4 h after administration. QTcF interval was significantly prolonged at 3 mg / kg by 8% -12% (26.3 -35.6 ng / mL) at 2 -4 h after administration and at 10 mg / kg by 9% - 16% (50.6 -86.6 ng / mL) at 1 -8 h after administration.
Results

Diurnal changes in RR and QT intervals
Distribution of QTc-RR plots
Effects of haloperidol
The mean blood pressure significantly rose 24 h after administration of haloperidol at 10 mg / kg. However, this change was not judged to be a direct effect of haloperidol since no alterations were noted in blood pressure around T max . The maximum plasma concentration (C max ) after administration of haloperidol was 7.0, 42.9, and 93.5 ng / mL at 1, 3, and 10 mg / kg, respectively; a dose-dependent increase in C max was noted. The time to the maximum plasma concentration (T max ) was between 3.3 and 4.5 h at all dose levels. Table 3 shows cardiovascular changes caused by dlpropranolol, and Table 4 shows changes in plasma concentration at the times when dl-propranolol caused these cardiovascular changes. Compared with the vehicle control group, dl-propranolol at 3, 10, and 30 mg / kg caused no changes in the mean blood pressure. Heart rate was significantly decreased at 3 and 10 mg / kg at 1 -24 h after administration and at 30 mg / kg at 2 -24 h after administration. dl-Propranolol at 10 and 30 mg / kg prolonged PR interval at 1 -4 h after administration. No changes were noted in QRS duration or QT interval, but QTcF interval was significantly shortened at 3 mg / kg by 8% -9% (3.3 -4.5 ng / mL) at 1 -2 h after administration; at 10 mg / kg, by 9% -10% (9.8 -16.4 ng / mL) at 1 -4 h after administration; and at 30 mg / kg, by 7% -12% (17.6 -67.3 ng / mL) at 1 -4 h after administration. Significant differences were sporadically seen in QTcF interval at 3 and 30 mg / kg at 24 h after administration. However, these changes were not judged to be adverse effects of administration since administration of vehicle did not alter the baseline values. C max after administration of dl-propranolol was 4.5, 16.9, and 69.3 ng / mL at 3, 10, and 30 mg / kg, respectively; a dose-dependent increase in C max was noted. T max was between 1 and 1.8 h at all dose levels. 
Effects of dl-propranolol
QTcF (362 ± 20 ms) Effects of dl-sotalol Table 5 shows cardiovascular changes caused by dlsotalol. Compared with the vehicle control values, dlsotalol at 10 mg/ kg caused no changes in the mean blood pressure. Heart rate tended to be decreased, but no statistically significant difference from the vehicle control values was seen. dl-Sotalol prolonged the PR interval 0.5 -4 h after administration. dl-Sotalol did not change QRS duration, but significantly prolonged QT interval by 3% -12% at 0.5 -4 h after administration and QTcF interval by 3% -7% at 1 -4 h after administration. The prolongation of QT interval 24 h after administration was judged to be an incidental change because the control heart rate at this time was lower than the baseline value. Figure 3 shows relationships between QTcF interval and plasma concentration of haloperidol and between QTcF interval and plasma concentration of dl-propranolol. QTcF interval was prolonged as plasma concentration of haloperidol was raised, and QTcF interval was shortened as plasma concentration of dl-propranolol was raised. There was a significant correlation between plasma concentration of haloperidol and QTcF interval (R 2 = 0.2123, P<0.001). Similarly, there was a significant correlation between plasma concentration of dlpropranolol and QTcF interval (R 2 = 0.1924, P<0.001).
Relationship between QTcF interval and plasma concentration
Discussion
In the present study, no differences were seen in diurnal changes in QT or RR interval for 24 h between the light period and the dark period in the miniature pigs. Nevertheless, Kuwahara et al. have reported that the heart rate increased during the light period and decreased during the dark period and the parasympathetic nervous activity was predominant during the dark period (22) . One of the factors responsible for the differences between the present study and that by Kuwahara et al. could be the feeding time. The animals were fed at approximately 18:30 in the present study to eliminate the effect of feeding on evaluation of cardiovascular parameters in the animals treated with haloperidol. At the pre-treatment recording for the QT-RR analysis, the feeding time was also set at around 18:30. Since the RR interval was short for no less than 3 h after the animals were fed in the present study, there is a possibility that feeding on a schedule confined to a time that falls just between night and day changed the rhythms during the dark period in the present study.
It is known that the QT interval is apt to be affected by heart rate. Therefore, QT interval was corrected using the RR interval to obtain QTcB interval, which was the QT interval corrected by Bazett's formula, and QTcF interval, which was the QT interval corrected by Fridericia's formula. Thus, the QTcB interval and QTcF interval are often subjected to evaluation of effects of extraneous substances, such as drugs and diets, on QT interval in dogs (16, 17, 23) . In the present study, we tried to evaluate the suitability of Bazett's and Fridericia's formulas for correcting the QT interval in miniature pigs. QT interval was not corrected accurately by Bazett's formula because the slope obtained by linear regression analysis of the distribution of QTc-RR plots for all animals was steep. On the other hand, the slope of linear regression for each animal by Fridericia's formula was significantly gentler than that by Bazett's formula, and no significant difference from that by individual correction was seen. The individual correction, a method to correct QT interval by determining a correction coefficient for each animal, has recently been regarded as important for accurate evaluation of QTc-interval changes in humans (24, 25) . The correction coefficient for QT interval, which was determined for each animal, in the individual correction method was similar to that in Fridericia's formula (coefficient β = 0.33). From the present data, we think that Fridericia's formula is adequate for providing an acceptable correction of the QT interval. However, taking it into consideration that in the present study, only 4 animals were used and QT interval was not adequately corrected in cases of extremely short and long RR interval, further detailed assessment is needed to recommend formulas suitable for correction of QT interval in miniature pigs. Haloperidol at 10 mg / kg prolonged QT interval by 15%, and at 3 and 10 mg / kg it also prolonged QTcF interval by 12% and 16%, respectively; C max after administration of haloperidol at 3 and 10 mg / kg was 42.9 and 93.5 ng / mL, respectively. It has been reported that haloperidol blocked the I Kr channel, prolonged QT interval (26) , and infrequently induced torsade de pointes in humans (5, 27) . It has also been reported that the therapeutic dose level of haloperidol is between 1 and 100 mg / day in humans (28) , and blood concentrations were between 8 and 20 ng / mL at the efficacious dose level of haloperidol (29) . Meanwhile C max was 7.6 ng / mL when humans were treated with 10 mg, at which haloperidol prolonged QTc interval by 8.8% (QTc = 421 ms) at 10 h after administration (30) . Considering that the blood concentration was 92 ng / mL at 8 h after torsade de pointes was induced in humans (29) , blood concentrations at which haloperidol prolonged QT interval in humans are considered to be between 7.6 and 92 ng / mL. Thus, the plasma concentrations (42.9 -93.5 ng / mL) at which haloperidol prolonged QT interval in the miniature pigs were almost comparable to those in humans. This fact suggests that QT interval is prolonged in miniature pigs at almost the same blood concentrations of haloperidol as in humans.
In a study with dogs performed in accordance with the standard protocol established by "QT PRODACT," haloperidol at 1 mg / kg, p.o. significantly prolonged QTcF interval by 19%, and C max was 44 ng / mL (31) . The plasma concentration was almost the same as C max (42.9 ng / mL) in the present study when the miniature pigs were treated with haloperidol at 3 mg / kg, p.o., a concentration that prolonged QTcF interval. Furthermore, in a study with monkeys performed in the same manner as the canine study, haloperidol did not affect the QTcB interval at 0.3, 1, or 3 mg / kg, p.o., and C max after administration of haloperidol at 3 mg / kg, p.o. was 13 ng/ mL (32) . The plasma concentration was almost the same as C max (7 ng / mL) in the present study when the miniature pigs were treated with haloperidol at 1 mg/ kg, p.o., a concentration that did not prolong the QTcF interval. From these facts, it can be said that there are no marked differences in sensitivity to the QTcF-prolongation effect of haloperidol between miniature pigs and dogs or between miniature pigs and monkeys.
Haloperidol at 10 mg / kg increased the mean blood pressure 24 h after administration. It has been reported that infusion of haloperidol at 3 mg / kg, i.v. decreased blood pressure and heart rate in anesthetized dogs (10) , and 50 mg of haloperidol injected intravenously over a period of 10 min decreased blood pressure in anesthetized pigs (33) . However, no reports on hemodynamic effects of haloperidol in conscious miniature pigs have ever been published. In the present study, an increase in blood pressure was noted 24 h after administration, but this is not considered to be a direct effect of haloperidol since there were no changes in blood pressure around T max .
As for dl-propranolol, it caused no alterations in QT interval at 3, 10, or 30 mg / kg, but dose-dependently shortened QTcF interval by 9% -12%. No reports have minutely examined the formulas for correcting QT interval in miniature pigs, so that it is difficult to examine the suitability of Fridericia's formula in the present study. The shortened QTcF interval has a possibility of being falsely noted since the QT interval was not adequately corrected due to the marked decrease in heart rate. It has been reported that dl-propranolol shortened the QTc interval both in humans who had the long QT interval syndrome (34) and in healthy humans (7) . In a study with canine Purkinje fibers and ventricular muscles, dl-propranolol at 0.9 µg/ mL shortened APD 50 and APD 90 (35) . In another study with guinea-pig ventricular muscles, dl-propranolol at 3 -30 µmol / L also shortened APD 30 , APD 60 , and APD 90 (36) . Plasma concentrations of dl-propranolol at which the shortened QTcF interval was noted in the present study were between 4.5 and 69.3 ng / mL, which were lower than the plasma concentration (68.3 ng / mL) of dl-propranolol at the efficacious dose level (1.3 mg / kg) in humans (13) . This finding may suggest that QT interval shortening by dl-propranolol can be detected in miniature pigs even at lower plasma concentrations than in humans. dl-Propra-nolol did not prolong QTc interval in dogs or monkeys as well as miniature pigs, but the shortening of the QTc interval was much less marked than that in the miniature pigs (31, 32) . Although we do not have sufficient information to clarify the cause of these findings, we considered that those are interesting facts. In addition, decrease in heart rate was caused by the β-receptorblocking effect of dl-propranolol at 3 and 10 mg / kg, and prolongation of PR interval was caused by an A-V blocking effect in miniature pigs.
dl-Sotalol, a representative compound known to prolong QT interval in dogs and monkeys (19, 37) also significantly prolonged QTcF interval by 7% in the miniature pigs. In a study performed in accordance with the standard protocol that was established by "QT PRODACT," dl-sotalol prolonged QTc interval by 10% or more at 10 mg / kg in dogs and at 5 mg / kg in monkeys (38) . Therefore, it can be said that the prolongation of QTcF interval by dl-sotalol can be detected in miniature pigs as well as dogs and monkeys. In addition, dl-sotalol causes a prolongation of PR interval caused by its A-V blocking effect; dl-sotalol exerted this effect on the PR interval in miniature pigs.
Our above results demonstrated that the miniature pig can be used for prediction of drug-induced prolongation of QT interval in humans and is one of the useful animal species to assess electrocardiograms in safety pharmacology studies.
